The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Sudan prepares plan to modernize agriculture
- Mauritania’s inflation rises 0.8% in December
- Algeria to boost pharma raw material production
- Oman planted more than 800,000 trees
- Brazil-Arab Gallery #46
- Brazilian agribusiness sets export record in 2025
- Brazil’s beef: Arab imports surge over 176%
- AFCON: Arab teams reach quarterfinals
